Major Companies Reinforce Their Presence in the Blood Bank Market

The blood bank industry is on track for significant expansion as advancements in technology and increasing investments drive growth. With evolving digital solutions and enhanced plasma collection efforts, this sector is poised to meet rising demands efficiently while maintaining quality and compliance. Let's explore the current market size, key players, emerging trends, and detailed segment analysis shaping the blood bank market's future.

Forecasting the Blood Bank Market Size Through 2030
The blood bank market is projected to reach a valuation of $26.59 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.8%. This upward trajectory is supported by greater investments in digital blood bank platforms and the wider adoption of remote donor engagement technologies. Additionally, the expansion of plasma collection networks, an increased focus on traceability and regulatory compliance, and rising demand for efficient blood logistics contribute significantly to this growth. Key trends expected to influence the market include the rising use of automated blood bank management systems, enhanced digital donor tracking, optimization of cold chain processes, the growth of mobile blood collection units, and a stronger emphasis on quality assurance and regulatory adherence.

Download a free sample of the blood bank market report:
https://www.thebusinessresearchcompany.com/report/blood-bank-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Organizations Dominating the Blood Bank Market
Several prominent companies shape the landscape of the blood bank industry, including American Association of Blood Banks, Blood Bank of Alaska, Canadian Blood Services, The Japanese Red Cross Society, New York Blood Center, NHS Blood And Transplant, Sanquin Blood Supply Foundation, The American Red Cross, Vitalant, America's Blood Centers, Australian Red Cross, Terumo Corporation, Haemonetics Corporation, National Blood Transfusion Council, Shire Plc, Abbott, Beckman Coulter Inc., Polymedicure, Thermo Fisher Scientific Inc., Becton dic*kinson and Company, Bio-Rad Laboratories Inc., F. Hoffman La Roche, Siemens Healthcare Private Limited, BioMérieux, CSL Behring, Takeda, Octapharma, Kedrion, Macopharma, Fresenius Kabi AG, B. Braun Melsungen AG, Grifols SA, Hologic Inc., Ortho Clinical Diagnostics, Merck KGaA, Roche Diagnostics, and Quotient Limited.

Strategic Acquisition Enhances Plasma Supply Capabilities
In December 2024, GC Biopharma Corp., a South Korea-based biopharmaceutical firm, acquired ABO Holdings, Inc., a US operator of plasma collection centers, for an undisclosed sum. This acquisition bolsters GC Biopharma's vertically integrated plasma supply chain and supports the expansion of its immunoglobulin business within the United States. ABO Holdings plays a crucial role by supplying source plasma, a vital component used in plasma-derived therapies, strengthening the company's position in this critical segment.

The blood bank industry is on track for significant expansion as advancements in technology and increasing investments drive growth. With evolving digital solutions and enhanced plasma collection efforts, this sector is poised to meet rising demands efficiently while maintaining quality and compliance. Let's explore the current market size, key players, emerging trends, and detailed segment analysis shaping the blood bank market's future.

Forecasting the Blood Bank Market Size Through 2030
The blood bank market is projected to reach a valuation of $26.59 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.8%. This upward trajectory is supported by greater investments in digital blood bank platforms and the wider adoption of remote donor engagement technologies. Additionally, the expansion of plasma collection networks, an increased focus on traceability and regulatory compliance, and rising demand for efficient blood logistics contribute significantly to this growth. Key trends expected to influence the market include the rising use of automated blood bank management systems, enhanced digital donor tracking, optimization of cold chain processes, the growth of mobile blood collection units, and a stronger emphasis on quality assurance and regulatory adherence.

Download a free sample of the blood bank market report:
https://www.thebusinessresearchcompany.com/report/blood-bank-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Organizations Dominating the Blood Bank Market
Several prominent companies shape the landscape of the blood bank industry, including American Association of Blood Banks, Blood Bank of Alaska, Canadian Blood Services, The Japanese Red Cross Society, New York Blood Center, NHS Blood And Transplant, Sanquin Blood Supply Foundation, The American Red Cross, Vitalant, America's Blood Centers, Australian Red Cross, Terumo Corporation, Haemonetics Corporation, National Blood Transfusion Council, Shire Plc, Abbott, Beckman Coulter Inc., Polymedicure, Thermo Fisher Scientific Inc., Becton dic*kinson and Company, Bio-Rad Laboratories Inc., F. Hoffman La Roche, Siemens Healthcare Private Limited, BioMérieux, CSL Behring, Takeda, Octapharma, Kedrion, Macopharma, Fresenius Kabi AG, B. Braun Melsungen AG, Grifols SA, Hologic Inc., Ortho Clinical Diagnostics, Merck KGaA, Roche Diagnostics, and Quotient Limited.

Strategic Acquisition Enhances Plasma Supply Capabilities
In December 2024, GC Biopharma Corp., a South Korea-based biopharmaceutical firm, acquired ABO Holdings, Inc., a US operator of plasma collection centers, for an undisclosed sum. This acquisition bolsters GC Biopharma's vertically integrated plasma supply chain and supports the expansion of its immunoglobulin business within the United States. ABO Holdings plays a crucial role by supplying source plasma, a vital component used in plasma-derived therapies, strengthening the company's position in this critical segment.

Technological Innovations Driving Change in the Blood Bank Sector
Key players are increasingly concentrating on technological enhancements, especially in clinical oncology next-generation sequencing (NGS). The integration of software accelerators drastically reduces both time and costs associated with second-level NGS analysis. This enables laboratories to provide quicker results while lowering computational resource demands. For example, in January 2024, Germany-based bioinformatics firm QIAGEN Digital Insights launched an upgraded version of its CLC Genomics Workbench Premium, featuring LightSpeed technology. This advancement supports somatic cancer secondary analysis and can process a 275-gene cancer panel at 3377× coverage in just six minutes, at a cost below US$ 0.72 per test in standard cloud environments. LightSpeed's design focuses on delivering high speed, precision, reduced power use, and does not require additional hardware or licenses beyond the existing CLC platform.

Detailed Market Segmentation and Forecast for the Blood Bank Industry
The global blood bank market is categorized into several segments for comprehensive analysis:
1) By Bank Type: Private Blood Bank and Public Blood Bank
2) By Function: Collection, Processing, Testing, Storage, Transportation
3) By Product Type: Whole Blood, Red Blood Cells, Platelet, Plasma, White Blood Cells
4) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Pharmaceutical Companies

Further subcategories include:
- Private Blood Bank: Commercial Blood Banks, Specialty Blood Banks
- Public Blood Bank: Government-Funded Blood Banks, Non-Profit Blood Banks

This segmentation offers an in-depth understanding of market dynamics and helps identify growth opportunities across different areas of the blood bank industry.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.